Comparison of Markov Model and Dynamic Model in Economic Evaluations for Infectious Diseases: A case of Bictegravir/emtricitabine/tenofovir Treatment-native adults of HIV-1 in China
Preprint in Research Square (February 2024)
The most recent citing publications are shown below. View all 7 publications that cite this research output on Dimensions.
Cost-effectiveness analysis of antiretroviral drugs for treatment-naive HIV infection in China
Article in BMC Public Health (November 2023)
Cost-effectiveness of dolutegravir vs. efavirenz-based combined antiretroviral therapies in HIV-infected treatment-naive patients in a Nigerian treatment centre
Article in African Health Sciences (March 2023)